A detailed history of Cutter & CO Brokerage, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Cutter & CO Brokerage, Inc. holds 117,623 shares of PFE stock, worth $3.27 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
117,623
Previous 104,331 12.74%
Holding current value
$3.27 Million
Previous $3 Million 8.69%
% of portfolio
0.88%
Previous 0.92%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $344,129 - $395,171
13,292 Added 12.74%
117,623 $3.26 Million
Q4 2023

Feb 01, 2024

BUY
$26.13 - $33.94 $2.25 Million - $2.92 Million
86,137 Added 473.44%
104,331 $3 Million
Q3 2023

Oct 31, 2023

BUY
$32.09 - $37.51 $77,016 - $90,024
2,400 Added 15.2%
18,194 $603,000
Q2 2023

Aug 01, 2023

BUY
$36.12 - $41.79 $18,060 - $20,895
500 Added 3.27%
15,794 $579,000
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $35,411 - $46,100
899 Added 6.25%
15,294 $623,000
Q4 2022

Feb 03, 2023

SELL
$41.75 - $54.5 $3,423 - $4,469
-82 Reduced 0.57%
14,395 $737,000
Q3 2022

Nov 03, 2022

SELL
$43.76 - $53.42 $38,552 - $47,063
-881 Reduced 5.74%
14,477 $634,000
Q2 2022

Jul 28, 2022

SELL
$46.53 - $55.17 $51,601 - $61,183
-1,109 Reduced 6.73%
15,358 $805,000
Q1 2022

May 03, 2022

BUY
$45.75 - $56.69 $157,288 - $194,900
3,438 Added 26.39%
16,467 $852,000
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $14,875 - $22,050
360 Added 2.84%
13,029 $769,000
Q3 2021

Nov 02, 2021

SELL
$39.25 - $50.42 $9,027 - $11,596
-230 Reduced 1.78%
12,669 $545,000
Q2 2021

Aug 09, 2021

BUY
$35.91 - $40.68 $3,016 - $3,417
84 Added 0.66%
12,899 $505,000
Q1 2021

May 11, 2021

SELL
$33.49 - $37.77 $52,210 - $58,883
-1,559 Reduced 10.85%
12,815 $464,000
Q4 2020

Feb 03, 2021

SELL
$33.47 - $42.56 $2,610 - $3,319
-78 Reduced 0.54%
14,374 $529,000
Q3 2020

Nov 05, 2020

BUY
$31.75 - $37.25 $24,034 - $28,198
757 Added 5.53%
14,452 $530,000
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $8,252 - $10,011
274 Added 2.04%
13,695 $448,000
Q1 2020

May 05, 2020

SELL
$27.03 - $38.62 $598,417 - $855,008
-22,139 Reduced 62.26%
13,421 $438,000
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $356,589 - $404,683
-10,832 Reduced 23.35%
35,560 $1.39 Million
Q3 2019

Nov 07, 2019

SELL
$32.49 - $42.13 $106,307 - $137,849
-3,272 Reduced 6.59%
46,392 $1.67 Million
Q2 2019

Jul 31, 2019

BUY
$36.98 - $41.52 $197,879 - $222,173
5,351 Added 12.08%
49,664 $2.15 Million
Q1 2019

Apr 23, 2019

SELL
$37.5 - $41.2 $32,850 - $36,091
-876 Reduced 1.94%
44,313 $1.88 Million
Q4 2018

Feb 07, 2019

BUY
$38.47 - $43.86 $90,558 - $103,246
2,354 Added 5.5%
45,189 $1.97 Million
Q3 2018

Oct 12, 2018

BUY
$34.47 - $41.81 $189,895 - $230,331
5,509 Added 14.76%
42,835 $1.89 Million
Q2 2018

Jul 30, 2018

SELL
$32.98 - $35.16 $11,312 - $12,059
-343 Reduced 0.91%
37,326 $1.35 Million
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $2,712 - $3,146
-85 Reduced 0.23%
37,669 $1.34 Million
Q4 2017

Jan 30, 2018

SELL
$33.26 - $35.29 $584,544 - $620,221
-17,575 Reduced 31.76%
37,754 $1.37 Million
Q3 2017

Oct 23, 2017

SELL
$31.0 - $34.15 $72,819 - $80,218
-2,349 Reduced 4.07%
55,329 $1.98 Million
Q2 2017

Aug 07, 2017

BUY
N/A
57,678
57,678 $1.94 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cutter & CO Brokerage, Inc. Portfolio

Follow Cutter & CO Brokerage, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.